COMBINED INHIBITION OF BTK AND PI3KΔ AS A POTENTIAL THERAPEUTIC STRATEGY IN MANTLE CELL LYMPHOMA

被引：0
|
作者：
Zhang, Yizhuo [1 ]
Qu, Fulian [1 ]
Xia, Bing [1 ]
Guo, Shanqi [1 ]
机构：
[1] Tianjin Canc Hosp, Tianjin, Peoples R China
来源：
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 10卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
241
引用
收藏
页码：139 / 139
页数：1
相关论文
共 50 条
  • [1] Combined inhibition of CDK and PI3K/Akt pathways induces apoptosis of mantle cell lymphoma
    Mohapatra, Subhra
    Chu, Baoky
    Zhao, Xiuhua
    Tao, Jianguo
    Sotomayor, Eduardo
    Pledger, W. Jack
    [J]. BLOOD, 2007, 110 (11) : 416A - 416A
  • [2] Combined inhibition of BTK and PI3K acts synergistically in a canine B-cell lymphoma in vitro model
    Kong, W.
    Sender, S.
    Sekora, A.
    Ma, Y.
    Ruetgen, B.
    Nolte, I.
    Taher, L.
    Brenig, B.
    Beck, J.
    Schuetz, E.
    Junghanss, C.
    Escobar, Murua H.
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 : 119 - 119
  • [3] PI3K Inhibition As a Potential Therapeutic Strategy in Peripheral T-Cell Lymphomas
    Martin-Sanchez, Esperanza
    Rodriguez-Pinilla, Socorro M.
    Lombardia, Luis
    Dominguez-Gonzalez, Beatriz
    Sanchez-Beato, Margarita
    Romero, Diana
    Wozniak, Magdalena B.
    Mollejo, Manuela
    Alves, Javier
    Luis Rodriguez-Peralto, Jose
    Menarguez, Javier
    Cigudosa, Juan C.
    Ortiz-Romero, Pablo L.
    Garcia, Juan F.
    Bischoff, James R.
    Piris, Miguel A.
    [J]. BLOOD, 2011, 118 (21) : 1490 - 1491
  • [4] Combinatorial inhibition of BTK, PI3K-AKT and BRD4-MYC as a strategy for treatment of mantle cell lymphoma
    Kendra R. Vann
    Dhananjaya Pal
    Audrey L. Smith
    Namood-e Sahar
    Maddeboina Krishnaiah
    Dalia El-Gamal
    Tatiana G. Kutateladze
    [J]. Molecular Biomedicine, 3
  • [5] Combinatorial inhibition of BTK, PI3K-AKT and BRD4-MYC as a strategy for treatment of mantle cell lymphoma
    Vann, Kendra R.
    Pal, Dhananjaya
    Smith, Audrey L.
    Sahar, Namood-E
    Krishnaiah, Maddeboina
    El-Gamal, Dalia
    Kutateladze, Tatiana G.
    [J]. MOLECULAR BIOMEDICINE, 2022, 3 (01):
  • [6] Inhibition of SRC-3 as a potential therapeutic strategy for aggressive mantle cell lymphoma
    Bijou, Imani
    Liu, Yang
    Lu, Dong
    Chen, Jianwei
    Sloan, Shelby
    Alinari, Lapo
    Lonard, David M.
    O'Malley, Bert W.
    Wang, Michael
    Wang, Jin
    [J]. PLOS ONE, 2024, 19 (04):
  • [7] PI3K a Selective Inhibitor Induces Growth Inhibition In Mantle Cell Lymphoma.
    Zhou, Yixin
    Jin, Linhua
    Pittaluga, Stefania
    Raffeld, Mark
    Miida, Takashi
    Tabe, Yoko
    [J]. BLOOD, 2010, 116 (21) : 757 - 757
  • [8] Roles of PI3Kγ and PI3Kδ in mantle cell lymphoma proliferation and migration contributing to efficacy of the PI3Kγ/δ inhibitor duvelisib
    Till, Kathleen J.
    Abdullah, Mariah
    Alnassfan, Tahera
    Janet, Gallardo Zapata
    Marks, Thomas
    Coma, Silvia
    Weaver, David T.
    Pachter, Jonathan A.
    Pettitt, Andrew R.
    Slupsky, Joseph R.
    [J]. SCIENTIFIC REPORTS, 2023, 13 (01)
  • [9] Cotargeting of PIM, PI3K and mTOR in mantle cell lymphoma
    Freysoldt, B.
    Schnaiter, A.
    Zimmermann, Y.
    Hutter, G.
    Hiddemann, W.
    Dreyling, M.
    [J]. Oncology Research and Treatment, 2015, 38 : 63 - 63
  • [10] Roles of PI3Kγ and PI3Kδ in mantle cell lymphoma proliferation and migration contributing to efficacy of the PI3Kγ/δ inhibitor duvelisib
    Kathleen J. Till
    Mariah Abdullah
    Tahera Alnassfan
    Gallardo Zapata Janet
    Thomas Marks
    Silvia Coma
    David T. Weaver
    Jonathan A. Pachter
    Andrew R. Pettitt
    Joseph R. Slupsky
    [J]. Scientific Reports, 13
12345